Tag: Sandoz

Debra BorchardtDecember 18, 2018
ClosingBell-tilray-Nasdaq-1280x854.jpg
Business

Tilray Signs Deal With Big Pharma Company Sandoz

3min00
Tilray Canada Ltd., a subsidiary of Tilray Inc. (NASDAQ: TLRY) entered into an agreement with Sandoz AG, which is a part of the Novartis group, to increase the availability of high-quality medical cannabis products across the world. According to the company statement, the Tilray and Sandoz agreement would be as follows: Sandoz AG may support […]
CONTINUE READING
Debra BorchardtMarch 19, 2018
brody-tilray-pack1-1280x675.jpg
Business

Canadian Cannabis Company Tilray Hooks Up With Big Pharma

3min00
Canadian medical marijuana company Tilray has signed a binding letter of intent (LOI) to collaborate with generic pharmaceutical company Sandoz Canada Inc., an affiliate of Sandoz International GmbH, which is part of the Novartis Group (NVS).  The two companies are working together in order to accelerate innovation and increase the availability of high-quality cannabis products. “This […]
CONTINUE READING

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up

About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis

READ MORE
Recent Tweets
Company

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.